Ischemic Heart Disease News and Research

RSS

Gender (dis)advantages in cardiac remodeling

The topic of gender-related differences in cardiac care is an extremely complex one. Unfortunately women have been neglected in several fields of medicine for too long. I think that cardiology is only one of the many fields in the past where the male predominance was obvious.

3 Sep 2007

Doubt raised again over value of antioxidant supplements

According to a new study by French researchers, antioxidant supplements do not protect women against skin cancer and in fact they may possibly increase their risk.

20 Aug 2007

Diabetes increases risk of death for patients with acute coronary syndromes

Individuals with diabetes and acute coronary syndromes (ACS) such as a heart attack or unstable angina have an increased risk of death at 30 days and one year after ACS, compared with ACS patients without diabetes, according to a study in the August 15 issue of JAMA .

16 Aug 2007

Elevated nonfasting triglyceride levels associated with heart attack

Results from two studies indicate that elevated nonfasting triglyceride levels are associated with cardiovascular events such as a heart attack, with one study finding that triglyceride levels measured after fasting does not show this association, according to studies in the July 18 issue of JAMA .

18 Jul 2007

Treating sub clinical hypothyroidism

Putting on weight and feeling lethargic? Then new research from Newcastle University and funded by Gateshead NHS Foundation Trust shows it is worth having your thyroid levels checked, as these can be symptoms of thyroid disease which is easily identified and treated.

30 May 2007

Cronic obstructive pulmonary disease is a major and increasing global health epidemic

Cronic obstructive pulmonary disease (COPD) is a major and increasing global health epidemic that has received insufficient attention from the health-care profession, governments, and the pharmaceutical industry, argues Professor Peter Barnes, one of the world's leading experts on lung disease.

16 May 2007

Genetic risk for early death in rheumatoid arthritis

A chronic autoimmune disease, rheumatoid arthritis (RA) is marked by inflammation that takes a progressive toll on not only the joints, but also various organs and the whole body.

30 Apr 2007

New data supports safety of ranolazine but not its effectiveness

The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA .

25 Apr 2007

Ranolazine safe but not effective in reducing major cardiac events in ACS patients

25 Apr 2007

Cytokinetics initiates of phase II clinical trial for CK-1827452

Cytokinetics has announced the initiation of a Phase II clinical trials program evaluating CK-1827452, a novel cardiac myosin activator for the potential treatment of patients with either acutely decompensated or chronic heart failure.

15 Apr 2007

Breath test to detect lung cancer

A new breath test has been reported to detect lung cancer in its early stage. Lung cancer is the leading cause of cancer death in the United States, and doctors believe that early detection could offer sufferers their best chance for early survival.

18 Feb 2007

In 25 years AIDS will be the number one killer disease

A study by World Health Organisation (WHO) researchers has predicted that by the year 2030 AIDS will claim as many as 6.5 million lives per year.

29 Nov 2006

Study highlights differences in Anthropometric characteristics between Asian and European population

World Congress of Cardiology Report - Results from a large scale international study assessing prevalence of abdominal obesity in over 170,000 people have previously confirmed that a high waist circumference is associated with cardiovascular disease (CVD) independently of body mass index (BMI) and age.

5 Sep 2006

Sonic hedgehog may help overcome problems associated with FGF2 and VEGF therapy

The newest concept for treating coronary artery disease is to induce hearts to grow their own new blood vessels to bypass damaged tissue or clogged arteries.

18 Jun 2006

Molecular pathway may contribute to age related diseases

A common molecular denominator in aging and many age-related diseases is oxidative stress.

1 Jun 2006

Short-term exposure to fine particulate matter increases hospital admissions for heart problems

Short-term exposure to fine particulate matter - the microscopic particles that pollute the air - increased hospital admissions for cardiovascular and respiratory disease among Medicare participants, according to a study of 204 U.S. urban counties conducted by researchers at the Johns Hopkins Bloomberg School of Public Health and Yale University’s environment school.

8 Mar 2006

First description of female-specific Ischemia Syndrome

Although ischemic heart disease - the reduction of blood flow that can lead to heart attacks - is often considered a "man's disease," it takes the lives of more women than men each year. In fact, in 2000, about 60,000 more women than men died from cardiovascular disease.

5 Feb 2006

Aspirin may not increase the risk of recurrent intracerebral hemorrhage

Aspirin is typically prescribed for people at risk of having an ischemic stroke to prevent blood clots. Because aspirin may cause bleeding, it is typically avoided in people who have had a hemorrhagic stroke, also called intracerebral hemorrhage.

25 Jan 2006

Histidine may be key to new therapies for cardiovascular disease

It's just one little amino acid, but it makes all the difference in protecting the heart from the harmful effects of heart attack and cardiac failure. Researchers from the University of Michigan Medical School suggest this amino acid, called histidine, could be the key to a new therapy for cardiovascular disease

23 Jan 2006

Tamoxifen reduces the risk of invasive and noninvasive breast cancer

Data from additional years of follow-up of a large randomized placebo-controlled clinical trial of tamoxifen for the prevention of breast cancer confirm that the drug reduces the risk of invasive and noninvasive breast cancer, according to a report that appears in the current issue of the Journal of the National Cancer Institute.

21 Nov 2005